A kit for improving gene editing efficiency and application thereof
By leveraging the synergistic effect of T5 exonuclease and histone deacetylase inhibitors, the problem of low editing efficiency of the CRISPR/Cas12i complex in eukaryotes has been solved, enabling efficient gene editing in different species and genes.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- INSTITUTE OF ANIMAL SCIENCES OF CHINESE ACADEMY OF AGRICULTURAL SCIENCES
- Filing Date
- 2026-04-01
- Publication Date
- 2026-06-12
AI Technical Summary
In eukaryotes, the gene editing efficiency of the CRISPR/Cas12i complex is limited by the spatial structure of chromatin, resulting in low editing efficiency, especially in large livestock.
The editing activity of Cas12iMax was enhanced by the synergistic effect of T5 exonuclease and histone deacetylase inhibitors (such as trichostatin A and ronostatin).
It significantly improves the gene editing efficiency of Cas12iMax in different species such as cattle, humans, and pigs, enhances the editing effect of multiple genes, and expands the scope of application.